Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension

Bioorg Med Chem Lett. 2013 Nov 1;23(21):5975-9. doi: 10.1016/j.bmcl.2013.08.054. Epub 2013 Aug 20.

Abstract

We identified 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase (sEH) inhibitors and orally active agents for treating hypertension. Docking studies using human and murine sEH X-ray crystal structures revealed steric hindrance around the side chain of Phe406 of murine sEH. The trifluoromethyl moiety (11) was replaced with a trifluoromethoxy moiety (12) to prevent steric clash, and improved murine sEH inhibitory activity was observed. The oral administration of 12, 20, and 37 at a dose of 30mg/kg reduced blood pressure in spontaneously hypertensive rat, but had little effect on blood pressure in normotensive rat.

Keywords: Hypertension; Mean blood pressure; Spirocyclic diamine; Spontaneously hypertensive rat; Urea; sEH inhibitor.

MeSH terms

  • Alkanes / chemistry
  • Alkanes / pharmacology
  • Alkanes / therapeutic use
  • Animals
  • Antihypertensive Agents / chemistry*
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Epoxide Hydrolases / antagonists & inhibitors*
  • Epoxide Hydrolases / chemistry
  • Epoxide Hydrolases / metabolism
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / enzymology
  • Molecular Docking Simulation
  • Rats
  • Rats, Inbred SHR
  • Urea / analogs & derivatives*
  • Urea / pharmacology
  • Urea / therapeutic use*

Substances

  • Alkanes
  • Antihypertensive Agents
  • Urea
  • Epoxide Hydrolases
  • decane